Complete financial analysis of Balaji Amines Limited (BALAMINES.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Balaji Amines Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- GD Entertainment & Technology, Inc. (GDET) Income Statement Analysis – Financial Results
- Super Energy Power Plant Infrastructure Fund (SUPEREIF.BK) Income Statement Analysis – Financial Results
- Avadel Pharmaceuticals plc (AVDL) Income Statement Analysis – Financial Results
- China Sanjiang Fine Chemicals Company Limited (2198.HK) Income Statement Analysis – Financial Results
- AGS Transact Technologies Limited (AGSTRA.NS) Income Statement Analysis – Financial Results
Balaji Amines Limited (BALAMINES.NS)
About Balaji Amines Limited
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and CFL Lamps. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, and choline chloride; and pharma excipients, such as poly vinyl pyrrolidone. It serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, and water treatment chemical industries. In addition, the company operates Balaji Sarovar, a hotel in Solapur, Maharashtra; and manufactures and sells CFL lamps. It also exports its products to the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and internationally. The company was incorporated in 1988 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.42B | 23.38B | 23.20B | 13.11B | 9.36B | 9.43B | 8.64B | 6.70B | 6.43B | 6.19B | 6.10B | 5.12B | 4.50B | 3.57B | 2.62B | 2.52B | 2.18B | 1.76B |
| Cost of Revenue | 9.14B | 14.99B | 14.64B | 7.72B | 6.23B | 6.19B | 5.56B | 4.18B | 4.47B | 4.51B | 4.69B | 3.89B | 2.64B | 2.94B | 2.01B | 2.00B | 1.65B | 1.47B |
| Gross Profit | 7.27B | 8.39B | 8.57B | 5.39B | 3.12B | 3.24B | 3.07B | 2.53B | 1.96B | 1.68B | 1.42B | 1.23B | 1.86B | 631.85M | 609.83M | 518.03M | 525.39M | 280.60M |
| Gross Profit Ratio | 44.29% | 35.88% | 36.92% | 41.10% | 33.38% | 34.37% | 35.57% | 37.68% | 30.45% | 27.18% | 23.21% | 23.96% | 41.36% | 17.69% | 23.29% | 20.58% | 24.12% | 15.99% |
| Research & Development | 7.09M | 12.16M | 5.60M | 9.44M | 5.38M | 4.92M | 4.95M | 5.59M | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 834.29M | 66.30M | 175.01M | 118.39M | 106.16M | 101.84M | 129.60M | 125.29M | 182.55M | 126.04M | 50.52M | 42.11M | 0.00 | 227.25M | 174.06M | 152.22M | 133.39M | 118.47M |
| Selling & Marketing | 889.00K | 1.04B | 1.20B | 843.31M | 686.93M | 700.05M | 645.13M | 493.78M | 271.04M | 262.82M | 244.88M | 196.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 835.18M | 1.11B | 1.37B | 961.70M | 793.09M | 801.89M | 774.73M | 619.07M | 453.59M | 388.86M | 295.40M | 238.35M | 0.00 | 227.25M | 174.06M | 152.22M | 133.39M | 118.47M |
| Other Expenses | 0.00 | 20.06M | 39.06M | 18.63M | 37.53M | 38.55M | 36.60M | 26.43M | 16.27M | 33.15M | 371.13K | 3.05M | 212.06M | -160.52M | 97.06M | 17.55M | 79.18M | 61.80M |
| Operating Expenses | 842.26M | 2.72B | 2.76B | 2.03B | 1.66B | 1.52B | 1.44B | 1.23B | 916.54M | 852.83M | 688.54M | 540.45M | 1.13B | 66.73M | 203.09M | 169.77M | 264.87M | 63.30M |
| Cost & Expenses | 9.99B | 17.71B | 17.40B | 9.75B | 7.90B | 7.71B | 7.01B | 5.41B | 5.39B | 5.36B | 5.37B | 4.43B | 3.76B | 3.01B | 2.21B | 2.17B | 1.92B | 1.54B |
| Interest Income | 217.43M | 38.91M | 6.13M | 5.76M | 12.13M | 3.72M | 3.82M | 3.87M | 8.24M | 7.90M | 6.39M | 5.49M | 4.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 64.42M | 82.65M | 131.14M | 158.91M | 203.08M | 109.25M | 66.64M | 111.99M | 204.06M | 317.75M | 284.00M | 242.20M | 212.06M | 135.58M | 97.06M | 101.86M | 79.18M | 61.80M |
| Depreciation & Amortization | 453.74M | 453.47M | 405.22M | 345.20M | 317.32M | 195.54M | 192.88M | 197.12M | 193.82M | 200.76M | 164.89M | 127.15M | 103.76M | 82.95M | 70.79M | 50.90M | 46.81M | 40.18M |
| EBITDA | 3.53B | 6.24B | 6.36B | 3.79B | 1.86B | 1.95B | 1.86B | 1.52B | 1.25B | 1.06B | 892.84M | 831.78M | 825.53M | 134.11M | 477.53M | 399.16M | 307.34M | 257.48M |
| EBITDA Ratio | 21.51% | 26.51% | 27.31% | 28.67% | 19.57% | 20.73% | 22.14% | 22.96% | 19.86% | 16.62% | 14.83% | 15.99% | 18.58% | 18.15% | 18.23% | 15.86% | 14.11% | 14.67% |
| Operating Income | 6.43B | 5.68B | 5.82B | 3.38B | 1.50B | 1.76B | 1.73B | 1.37B | 879.59M | 510.65M | 740.28M | 459.41M | 739.25M | 565.12M | 410.38M | 348.26M | 263.07M | 220.41M |
| Operating Income Ratio | 39.16% | 24.31% | 25.10% | 25.78% | 16.02% | 18.65% | 19.97% | 20.42% | 13.68% | 8.25% | 12.13% | 8.98% | 16.45% | 15.83% | 15.67% | 13.84% | 12.08% | 12.56% |
| Total Other Income/Expenses | -3.41B | -4.42B | -27.08M | -106.72M | -148.67M | -69.46M | 30.92M | -36.75M | -159.40M | -317.31M | -436.56M | -229.45M | -212.06M | -116.27M | -93.42M | -101.86M | -76.64M | -58.70M |
| Income Before Tax | 3.02B | 5.67B | 5.78B | 3.27B | 1.31B | 1.69B | 1.66B | 1.26B | 879.59M | 510.65M | 456.28M | 459.41M | 527.20M | 429.54M | 313.32M | 246.40M | 183.89M | 158.61M |
| Income Before Tax Ratio | 18.37% | 24.25% | 24.92% | 24.90% | 14.01% | 17.88% | 19.20% | 18.75% | 13.68% | 8.25% | 7.48% | 8.98% | 11.73% | 12.03% | 11.96% | 9.79% | 8.44% | 9.04% |
| Income Tax Expense | 692.53M | 1.61B | 1.60B | 831.00M | 336.33M | 515.27M | 526.57M | 433.44M | 303.45M | 178.68M | 121.20M | -147.72M | 170.79M | 163.64M | 109.15M | 95.77M | 53.99M | 58.24M |
| Net Income | 2.05B | 3.26B | 3.68B | 2.38B | 1.05B | 1.17B | 1.13B | 823.52M | 576.13M | 331.97M | 335.08M | 311.69M | 356.41M | 265.89M | 204.17M | 150.63M | 129.90M | 100.37M |
| Net Income Ratio | 12.48% | 13.93% | 15.88% | 18.16% | 11.20% | 12.42% | 13.11% | 12.28% | 8.96% | 5.36% | 5.49% | 6.09% | 7.93% | 7.45% | 7.80% | 5.98% | 5.96% | 5.72% |
| EPS | 63.22 | 100.47 | 113.71 | 73.51 | 32.34 | 36.14 | 34.93 | 25.42 | 17.78 | 10.25 | 10.34 | 9.62 | 11.00 | 8.21 | 5.07 | 3.82 | 4.01 | 3.10 |
| EPS Diluted | 63.22 | 100.47 | 113.71 | 73.51 | 32.34 | 36.14 | 34.93 | 25.42 | 17.78 | 10.25 | 10.34 | 9.62 | 11.00 | 8.21 | 5.07 | 3.82 | 4.01 | 3.10 |
| Weighted Avg Shares Out | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 33.44M | 32.41M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M |
| Weighted Avg Shares Out (Dil) | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 33.44M | 32.41M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M | 32.40M |
Source: https://incomestatements.info
Category: Stock Reports